Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q54222617
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241121000317.0 |
008
|
|
|
241121nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q54222617
|
024
|
|
|
‡a
0000-0002-9951-7979
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q54222617
|
100
|
0 |
|
‡a
Luis I Fernández-Salazar
‡9
ast
‡9
es
‡9
sl
|
375
|
|
|
‡a
1
‡2
iso5218
|
400
|
0 |
|
‡a
Luis I Fernández-Salazar
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
Luis I Fernández-Salazar
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's Abdominal mass, multiple lymphadenopathies, and polyposis
|
670
|
|
|
‡a
Author's Accuracy of Urea Breath Test Performed Immediately After Emergency Endoscopy in Peptic Ulcer Bleeding
|
670
|
|
|
‡a
Author's Acute esophageal necrosis resolved in 72 hours.
|
670
|
|
|
‡a
Author's Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry
|
670
|
|
|
‡a
Author's Altered human gut dendritic cell properties in ulcerative colitis are reversed by Lactobacillus plantarum extracellular encrypted peptide STp.
|
670
|
|
|
‡a
Author's [Amebiasis and intestinal inflammatory disease]
|
670
|
|
|
‡a
Author's An unexpected finding of cat scratch colon in a screening colonoscopy
|
670
|
|
|
‡a
Author's [Annular pancreas: a potentially overlooked congenital pancreatic anomaly]
|
670
|
|
|
‡a
Author's Another multiple gastric anisakiasis case
|
670
|
|
|
‡a
Author's [Antral vascular ectasia: etiopathogenic, clinical, and therapeutic aspects]
|
670
|
|
|
‡a
Author's Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis
|
670
|
|
|
‡a
Author's Are Worries and Concerns Information Side Effects?
|
670
|
|
|
‡a
Author's Ascorbate-dependent decrease of the mucosal immune inflammatory response to gliadin in coeliac disease patients.
|
670
|
|
|
‡a
Author's Atmospheric pressure does not influence acute diverticular disease
|
670
|
|
|
‡a
Author's [Autoimmune pancreatitis: response to corticoids test]
|
670
|
|
|
‡a
Author's Cat scratch esophagus
|
670
|
|
|
‡a
Author's [Changes in iron metabolism in chronic hepatitis C]
|
670
|
|
|
‡a
Author's Chemokine (C-C Motif) Receptor 2 Mediates Dendritic Cell Recruitment to the Human Colon but Is Not Responsible for Differences Observed in Dendritic Cell Subsets, Phenotype, and Function Between the Proximal and Distal Colon
|
670
|
|
|
‡a
Author's Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study
|
670
|
|
|
‡a
Author's Clinical status, quality of life, and work productivity in Crohn's disease patients after one year of treatment with adalimumab.
|
670
|
|
|
‡a
Author's Collagenous colitis: Requirement for high-dose budesonide as maintenance treatment.
|
670
|
|
|
‡a
Author's [Colonic polyps: dysplasia predictive factors]
|
670
|
|
|
‡a
Author's Corrigendum: Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.
|
670
|
|
|
‡a
Author's Crohn's disease diagnosis during adalimumab treatment.
|
670
|
|
|
‡a
Author's Current concepts on microscopic colitis: evidence-based statements and recommendations of the Spanish Microscopic Colitis Group.
|
670
|
|
|
‡a
Author's Detection of specific IgA antibodies against a novel deamidated 8-Mer gliadin peptide in blood plasma samples from celiac patients
|
670
|
|
|
‡a
Author's [Diagnostic problems in adult celiac disease]
|
670
|
|
|
‡a
Author's Differential diagnosis and management of histologic eosinophilic colitis
|
670
|
|
|
‡a
Author's Doubts and similarities between Crohn's disease and Henoch-Schönlein purpura
|
670
|
|
|
‡a
Author's Duodenal lymphogram as a complementary tool in the diagnosis of celiac disease in adults
|
670
|
|
|
‡a
Author's Early Thiopurine Treatment Is Probably Beneficial but Time From Diagnosis Must Be Evaluated.
|
670
|
|
|
‡a
Author's Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry
|
670
|
|
|
‡a
Author's [Efficacy of thalidomide in digestive bleeding caused by angiodysplasias]
|
670
|
|
|
‡a
Author's [Elevated transaminase levels in adult celiac disease]
|
670
|
|
|
‡a
Author's [Endoscopic appearance of the duodenal bulb in adult celiac disease]
|
670
|
|
|
‡a
Author's [Endoscopy in celiac disease]
|
670
|
|
|
‡a
Author's Eosinophilic esophagitis after an episode of herpetic esophagitis
|
670
|
|
|
‡a
Author's EUS-guided choledochoduodenostomy with lumen-apposing metal stent after failed rendezvous in synchronous malignant biliary and gastric outlet obstruction (with video)
|
670
|
|
|
‡a
Author's Even non-experts identify non-dysplastic lesions in inflammatory bowel disease via chromoendoscopy: results of a screening program in real-life
|
670
|
|
|
‡a
Author's Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
|
670
|
|
|
‡a
Author's Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry.
|
670
|
|
|
‡a
Author's Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients
|
670
|
|
|
‡a
Author's Frequency, predictors, and consequences of maintenance infliximab therapy intensification in ulcerative colitis
|
670
|
|
|
‡a
Author's Gastric metastasis from renal cell carcinoma
|
670
|
|
|
‡a
Author's [Gastrointestinal stromal tumors (GISTs): clinical aspects]
|
670
|
|
|
‡a
Author's H. pylori-negative duodenal ulcer prevalence and causes in 774 patients
|
670
|
|
|
‡a
Author's [Hamartomatous polyp of the hypopharynx]
|
670
|
|
|
‡a
Author's Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments.
|
670
|
|
|
‡a
Author's High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD
|
670
|
|
|
‡a
Author's Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients.
|
670
|
|
|
‡a
Author's Human colon-derived soluble factors modulate gut microbiota composition.
|
670
|
|
|
‡a
Author's [Hydatidic cyst fistulized to colon]
|
670
|
|
|
‡a
Author's IFN beta 1b induced celiac disease
|
670
|
|
|
‡a
Author's IL-6 promotes immune responses in human ulcerative colitis and induces a skin-homing phenotype in the dendritic cells and Tcells they stimulate
|
670
|
|
|
‡a
Author's IL6, IL10 and TGFB1 gene polymorphisms in coeliac disease: differences between DQ2 positive and negative patients
|
670
|
|
|
‡a
Author's Immune thrombocytopenic purpura associated with inactive ulcerative colitis in chronic treatment with adalimumab
|
670
|
|
|
‡a
Author's Impact of the endoscopist's experience on the negative predictive value of capsule endoscopy.
|
670
|
|
|
‡a
Author's [Incidence and pathogenesis of acute pancreatitis in Crohn disease]
|
670
|
|
|
‡a
Author's Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study
|
670
|
|
|
‡a
Author's Increased Intraepithelial Vα24 Invariant NKT Cells in the Celiac Duodenum
|
670
|
|
|
‡a
Author's Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study).
|
670
|
|
|
‡a
Author's Interleukin 18 maintains a long-standing inflammation in coeliac disease patients
|
670
|
|
|
‡a
Author's Iron overload and genotype 3 are associated with liver steatosis in chronic hepatitis C.
|
670
|
|
|
‡a
Author's Is gliadin really safe for non-coeliac individuals? Production of interleukin 15 in biopsy culture from non-coeliac individuals challenged with gliadin peptides
|
670
|
|
|
‡a
Author's Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.
|
670
|
|
|
‡a
Author's [Lymphadenomegaly or papillar process?]
|
670
|
|
|
‡a
Author's Meckel's diverticulum and enteroliths complicating Crohn's disease
|
670
|
|
|
‡a
Author's [Meckel's diverticulum and gastrointestinal stromal tumor: an unusual association]
|
670
|
|
|
‡a
Author's Natural history of irritable bowel syndrome.
|
670
|
|
|
‡a
Author's Neuroendocrine tumor associate with inflammatory bowel disease: two cases report
|
670
|
|
|
‡a
Author's No increase in Epstein-Barr virus viral load in a group of 30 asymptomatic patients with Crohn's disease.
|
670
|
|
|
‡a
Author's NOD2/CARD15 gene mutations in patients with inflammatory bowel disease in Valladolid
|
670
|
|
|
‡a
Author's Nodular colonic lesion in a nephrectomized patient
|
670
|
|
|
‡a
Author's [Non-alcoholic fatty liver disease, serum iron indexes and iron concentration in the liver].
|
670
|
|
|
‡a
Author's Octreotide and angiodysplasia
|
670
|
|
|
‡a
Author's Percutaneous liver biopsy: patients' point of view
|
670
|
|
|
‡a
Author's [Pericholangitis and primary sclerosing cholangitis]
|
670
|
|
|
‡a
Author's Pitavastatin: other statin to be used and monitored
|
670
|
|
|
‡a
Author's Predictable bad evolution of an acute pancreatitis
|
670
|
|
|
‡a
Author's Prevalence and factors associated with poor sleep quality in inflammatory bowel disease outpatients
|
670
|
|
|
‡a
Author's [Primary prophylaxis of post-polylipectomy bleeding with clips]
|
670
|
|
|
‡a
Author's Radiation enteritidis diagnosed by wireless capsule endoscopy
|
670
|
|
|
‡a
Author's Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
|
670
|
|
|
‡a
Author's Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) y de la Confederación de Asociaciones de Enfermedad de Crohn y Colitis Ulcerosa (ACCU) para el manejo de los aspectos psicológicos en la enfermedad in
|
670
|
|
|
‡a
Author's [Relapsing colitis cystica profunda]
|
670
|
|
|
‡a
Author's Resources Utilization and Costs the Year Before and After Starting Treatment with Adalimumab in Crohn's Disease Patients
|
670
|
|
|
‡a
Author's [Respiratory insufficiency, vomiting and diarrhea in a Down's syndrome patient]
|
670
|
|
|
‡a
Author's Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease
|
670
|
|
|
‡a
Author's [Solid liver mass. Studies with nuclear medicine]
|
670
|
|
|
‡a
Author's Spontaneous bacterial peritonitis due to Gemella morbillorum in a patient under chronic treatment with norfloxacin
|
670
|
|
|
‡a
Author's [Study of gastronitestinal transit times with capsule endoscopy]
|
670
|
|
|
‡a
Author's [Submucosal tumor at the bottom of the cecum]
|
670
|
|
|
‡a
Author's [Synchronic MALT lymphoma and carcinoid tumor of the ileum]
|
670
|
|
|
‡a
Author's The concerns of Spanish patients with inflammatory bowel disease as measured by the RFIPC questionnaire.
|
670
|
|
|
‡a
Author's The simultaneous high expression of Vα24, IFN-γ and FoxP3 characterizes the liver of children with type I autoimmune hepatitis.
|
670
|
|
|
‡a
Author's The utility of faecal calprotectin to predict post-operative recurrence in Crohńs disease
|
670
|
|
|
‡a
Author's Treating Helicobacter pylori infection in the face of growing antibiotic resistance
|
670
|
|
|
‡a
Author's [Triple pylorus or double antroduodenal fistula]
|
670
|
|
|
‡a
Author's Tuberculosis, one more consideration in the differential diagnosis of a pancreatic mass
|
670
|
|
|
‡a
Author's [Ulcerative colitis and autoimmune hemolytic anemia]
|
670
|
|
|
‡a
Author's Using the internet to evaluate the opinion of patients with inflammatory bowel disease with regard to the available information.
|
670
|
|
|
‡a
Author's Villous atrophy persistence in celiac disease despite following a gluten-free diet must be clarified
|
670
|
|
|
‡a
Author's [Visceral leishmaniasis diagnosed by duodenal biopsy]
|
909
|
|
|
‡a
(orcid) 0000000299517979
‡9
1
|
919
|
|
|
‡a
differentialdiagnosisandmanagementofhistologiceosinophiliccolitis
‡A
Differential diagnosis and management of histologic eosinophilic colitis
‡9
1
|
919
|
|
|
‡a
duodenallymphogramasacomplementarytoolinthediagnosisofceliacdiseaseinadults
‡A
Duodenal lymphogram as a complementary tool in the diagnosis of celiac disease in adults
‡9
1
|
919
|
|
|
‡a
earlythiopurinetreatmentisprobablybeneficialbuttimefromdiagnosismustbeevaluated
‡A
Early Thiopurine Treatment Is Probably Beneficial but Time From Diagnosis Must Be Evaluated.
‡9
1
|
919
|
|
|
‡a
effectivenessandsafetyofthesequentialuseofa2and3antitnfagentinpatientswithinflammatoryboweldiseaseresultsfromtheeneidaregistry
‡A
Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry
‡9
1
|
919
|
|
|
‡a
efficacyofthalidomideindigestivebleedingcausedbyangiodysplasias
‡A
[Efficacy of thalidomide in digestive bleeding caused by angiodysplasias]
‡9
1
|
919
|
|
|
‡a
elevatedtransaminaselevelsinadultceliacdisease
‡A
[Elevated transaminase levels in adult celiac disease]
‡9
1
|
919
|
|
|
‡a
endoscopicappearanceoftheduodenalbulbinadultceliacdisease
‡A
[Endoscopic appearance of the duodenal bulb in adult celiac disease]
‡9
1
|
919
|
|
|
‡a
endoscopyinceliacdisease
‡A
[Endoscopy in celiac disease]
‡9
1
|
919
|
|
|
‡a
eosinophilicesophagitisafteranepisodeofherpeticesophagitis
‡A
Eosinophilic esophagitis after an episode of herpetic esophagitis
‡9
1
|
919
|
|
|
‡a
eusguidedcholedochoduodenostomywithlumenapposingmetalstentafterfailedrendezvousinsynchronousmalignantbiliaryandgastricoutletobstructionwithvideo
‡A
EUS-guided choledochoduodenostomy with lumen-apposing metal stent after failed rendezvous in synchronous malignant biliary and gastric outlet obstruction (with video)
‡9
1
|
919
|
|
|
‡a
evennonexpertsidentifynondysplasticlesionsininflammatoryboweldiseaseviachromoendoscopyresultsofascreeningprograminreallife
‡A
Even non-experts identify non-dysplastic lesions in inflammatory bowel disease via chromoendoscopy: results of a screening program in real-life
‡9
1
|
919
|
|
|
‡a
evolutionafterantitnfdiscontinuationinpatientswithinflammatoryboweldiseaseamulticenterlongtermfollowupstudy
‡A
Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
‡9
1
|
919
|
|
|
‡a
extracoloniccancerininflammatoryboweldiseasedatafromthegeteccueneidaregistry
‡A
Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry.
‡9
1
|
919
|
|
|
‡a
fecalglutenpeptidesreveallimitationsofserologicaltestsandfoodquestionnairesformonitoringglutenfreedietinceliacdiseasepatients
‡A
Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients
‡9
1
|
919
|
|
|
‡a
frequencypredictorsandconsequencesofmaintenanceinfliximabtherapyintensificationinulcerativecolitis
‡A
Frequency, predictors, and consequences of maintenance infliximab therapy intensification in ulcerative colitis
‡9
1
|
919
|
|
|
‡a
gastricmetastasisfromrenalcellcarcinoma
‡A
Gastric metastasis from renal cell carcinoma
‡9
1
|
919
|
|
|
‡a
gastrointestinalstromaltumorsgistsclinicalaspects
‡A
[Gastrointestinal stromal tumors (GISTs): clinical aspects]
‡9
1
|
919
|
|
|
‡a
hpylorinegativeduodenalulcerprevalenceandcausesin774patients
‡A
H. pylori-negative duodenal ulcer prevalence and causes in 774 patients
‡9
1
|
919
|
|
|
‡a
hamartomatouspolypofthehypopharynx
‡A
[Hamartomatous polyp of the hypopharynx]
‡9
1
|
919
|
|
|
‡a
helicobacterpylori2linerescuetherapywithlevofloxacinandbismuthcontainingquadrupletherapyafterfailureofstandardtripleornonbismuthquadrupletreatments
‡A
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments.
‡9
1
|
919
|
|
|
‡a
highlevelsofproinflammatorycytokinesbutnotmarkersoftissueinjuryinunaffectedintestinalareasfrompatientswithibd
‡A
High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD
‡9
1
|
919
|
|
|
‡a
higherconstitutiveil15ralphaexpressionandloweril15responsethresholdincoeliacdiseasepatients
‡A
Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients.
‡9
1
|
919
|
|
|
‡a
humancolonderivedsolublefactorsmodulategutmicrobiotacomposition
‡A
Human colon-derived soluble factors modulate gut microbiota composition.
‡9
1
|
919
|
|
|
‡a
hydatidiccystfistulizedtocolon
‡A
[Hydatidic cyst fistulized to colon]
‡9
1
|
919
|
|
|
‡a
ifnbeta1binducedceliacdisease
‡A
IFN beta 1b induced celiac disease
‡9
1
|
919
|
|
|
‡a
6promotesimmuneresponsesinhumanulcerativecolitisandinducesaskinhomingphenotypeinthedendriticcellsandtcellstheystimulate
‡A
IL-6 promotes immune responses in human ulcerative colitis and induces a skin-homing phenotype in the dendritic cells and Tcells they stimulate
‡9
1
|
919
|
|
|
‡a
il6il10andtgfb1genepolymorphismsincoeliacdiseasedifferencesbetweendq2positiveandnegativepatients
‡A
IL6, IL10 and TGFB1 gene polymorphisms in coeliac disease: differences between DQ2 positive and negative patients
‡9
1
|
919
|
|
|
‡a
immunethrombocytopenicpurpuraassociatedwithinactiveulcerativecolitisinchronictreatmentwithadalimumab
‡A
Immune thrombocytopenic purpura associated with inactive ulcerative colitis in chronic treatment with adalimumab
‡9
1
|
919
|
|
|
‡a
impactoftheendoscopistsexperienceonthenegativepredictivevalueofcapsuleendoscopy
‡A
Impact of the endoscopist's experience on the negative predictive value of capsule endoscopy.
‡9
1
|
919
|
|
|
‡a
incidenceandpathogenesisofacutepancreatitisincrohndisease
‡A
[Incidence and pathogenesis of acute pancreatitis in Crohn disease]
‡9
1
|
919
|
|
|
‡a
incidenceclinicalcharacteristicsandmanagementofpsoriasisinducedbyantitnftherapyinpatientswithinflammatoryboweldiseaseanationwidecohortstudy
‡A
Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study
‡9
1
|
919
|
|
|
‡a
increasedintraepithelialvα24invariantnktcellsintheceliacduodenum
‡A
Increased Intraepithelial Vα24 Invariant NKT Cells in the Celiac Duodenum
‡9
1
|
919
|
|
|
‡a
infliximabinulcerativecolitisreallifeanalysisoffactorspredictingtreatmentdiscontinuationduetolackofresponseorcolectomyeciaacadcolitisandinfliximabstudy
‡A
Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study).
‡9
1
|
919
|
|
|
‡a
interleukin18maintainsalongstandinginflammationincoeliacdiseasepatients
‡A
Interleukin 18 maintains a long-standing inflammation in coeliac disease patients
‡9
1
|
919
|
|
|
‡a
ironoverloadandgenotype3areassociatedwithliversteatosisinchronichepatitis100
‡A
Iron overload and genotype 3 are associated with liver steatosis in chronic hepatitis C.
‡9
1
|
919
|
|
|
‡a
isgliadinreallysafefornoncoeliacindividualsproductionofinterleukin15inbiopsyculturefromnoncoeliacindividualschallengedwithgliadinpeptides
‡A
Is gliadin really safe for non-coeliac individuals? Production of interleukin 15 in biopsy culture from non-coeliac individuals challenged with gliadin peptides
‡9
1
|
919
|
|
|
‡a
longtermsafetyofinuteroexposuretoantitnfαdrugsforthetreatmentofinflammatoryboweldiseaseresultsfromthemulticentereuropeanteddystudy
‡A
Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.
‡9
1
|
919
|
|
|
‡a
lymphadenomegalyorpapillarprocess
‡A
[Lymphadenomegaly or papillar process?]
‡9
1
|
919
|
|
|
‡a
meckelsdiverticulumandenterolithscomplicatingcrohnsdisease
‡A
Meckel's diverticulum and enteroliths complicating Crohn's disease
‡9
1
|
919
|
|
|
‡a
meckelsdiverticulumandgastrointestinalstromaltumoranunusualassociation
‡A
[Meckel's diverticulum and gastrointestinal stromal tumor: an unusual association]
‡9
1
|
919
|
|
|
‡a
naturalhistoryofirritablebowelsyndrome
‡A
Natural history of irritable bowel syndrome.
‡9
1
|
919
|
|
|
‡a
neuroendocrinetumorassociatewithinflammatoryboweldisease2casesreport
‡A
Neuroendocrine tumor associate with inflammatory bowel disease: two cases report
‡9
1
|
919
|
|
|
‡a
noincreaseinepsteinbarrvirusviralloadinagroupof30asymptomaticpatientswithcrohnsdisease
‡A
No increase in Epstein-Barr virus viral load in a group of 30 asymptomatic patients with Crohn's disease.
‡9
1
|
919
|
|
|
‡a
nod2card15genemutationsinpatientswithinflammatoryboweldiseaseinvalladolid
‡A
NOD2/CARD15 gene mutations in patients with inflammatory bowel disease in Valladolid
‡9
1
|
919
|
|
|
‡a
nodularcoloniclesioninanephrectomizedpatient
‡A
Nodular colonic lesion in a nephrectomized patient
‡9
1
|
919
|
|
|
‡a
nonalcoholicfattyliverdiseaseserumironindexesandironconcentrationintheliver
‡A
[Non-alcoholic fatty liver disease, serum iron indexes and iron concentration in the liver].
‡9
1
|
919
|
|
|
‡a
octreotideandangiodysplasia
‡A
Octreotide and angiodysplasia
‡9
1
|
919
|
|
|
‡a
percutaneousliverbiopsypatientspointofview
‡A
Percutaneous liver biopsy: patients' point of view
‡9
1
|
919
|
|
|
‡a
pericholangitisandprimarysclerosingcholangitis
‡A
[Pericholangitis and primary sclerosing cholangitis]
‡9
1
|
919
|
|
|
‡a
pitavastatinotherstatintobeusedandmonitored
‡A
Pitavastatin: other statin to be used and monitored
‡9
1
|
919
|
|
|
‡a
predictablebadevolutionofanacutepancreatitis
‡A
Predictable bad evolution of an acute pancreatitis
‡9
1
|
919
|
|
|
‡a
prevalenceandfactorsassociatedwithpoorsleepqualityininflammatoryboweldiseaseoutpatients
‡A
Prevalence and factors associated with poor sleep quality in inflammatory bowel disease outpatients
‡9
1
|
919
|
|
|
‡a
primaryprophylaxisofpostpolylipectomybleedingwithclips
‡A
[Primary prophylaxis of post-polylipectomy bleeding with clips]
‡9
1
|
919
|
|
|
‡a
radiationenteritidisdiagnosedbywirelesscapsuleendoscopy
‡A
Radiation enteritidis diagnosed by wireless capsule endoscopy
‡9
1
|
919
|
|
|
‡a
recomendacionesdelgrupoespanoldetrabajoenenfermedaddecrohnycolitisulcerosa
‡A
Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
‡9
1
|
919
|
|
|
‡a
recomendacionesdelgrupoespanoldetrabajoenenfermedaddecrohnycolitisulcerosageteccuydelaconfederaciondeasociacionesdeenfermedaddecrohnycolitisulcerosaaccuparaelmanejodelosaspectospsicologicosenlaenfermedadin
‡A
Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) y de la Confederación de Asociaciones de Enfermedad de Crohn y Colitis Ulcerosa (ACCU) para el manejo de los aspectos psicológicos en la enfermedad in
‡9
1
|
919
|
|
|
‡a
relapsingcolitiscysticaprofunda
‡A
[Relapsing colitis cystica profunda]
‡9
1
|
919
|
|
|
‡a
resourcesutilizationandcoststheyearbeforeandafterstartingtreatmentwithadalimumabincrohnsdiseasepatients
‡A
Resources Utilization and Costs the Year Before and After Starting Treatment with Adalimumab in Crohn's Disease Patients
‡9
1
|
919
|
|
|
‡a
respiratoryinsufficiencyvomitinganddiarrheainadownssyndromepatient
‡A
[Respiratory insufficiency, vomiting and diarrhea in a Down's syndrome patient]
‡9
1
|
919
|
|
|
‡a
serialtuberculinskintestsimprovethedetectionoflatenttuberculosisinfectioninpatientswithinflammatoryboweldisease
‡A
Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease
‡9
1
|
919
|
|
|
‡a
solidlivermassstudieswithnuclearmedicine
‡A
[Solid liver mass. Studies with nuclear medicine]
‡9
1
|
919
|
|
|
‡a
spontaneousbacterialperitonitisduetogemellamorbilloruminapatientunderchronictreatmentwithnorfloxacin
‡A
Spontaneous bacterial peritonitis due to Gemella morbillorum in a patient under chronic treatment with norfloxacin
‡9
1
|
919
|
|
|
‡a
studyofgastronitestinaltransittimeswithcapsuleendoscopy
‡A
[Study of gastronitestinal transit times with capsule endoscopy]
‡9
1
|
919
|
|
|
‡a
submucosaltumoratthebottomofthececum
‡A
[Submucosal tumor at the bottom of the cecum]
‡9
1
|
919
|
|
|
‡a
synchronicmaltlymphomaandcarcinoidtumoroftheileum
‡A
[Synchronic MALT lymphoma and carcinoid tumor of the ileum]
‡9
1
|
919
|
|
|
‡a
concernsofspanishpatientswithinflammatoryboweldiseaseasmeasuredbytherfipcquestionnaire
‡A
The concerns of Spanish patients with inflammatory bowel disease as measured by the RFIPC questionnaire.
‡9
1
|
919
|
|
|
‡a
simultaneoushighexpressionofvα24ifnγandfoxp3characterizestheliverofchildrenwithtype1autoimmunehepatitis
‡A
The simultaneous high expression of Vα24, IFN-γ and FoxP3 characterizes the liver of children with type I autoimmune hepatitis.
‡9
1
|
919
|
|
|
‡a
utilityoffaecalcalprotectintopredictpostoperativerecurrenceincrohnsdisease
‡A
The utility of faecal calprotectin to predict post-operative recurrence in Crohńs disease
‡9
1
|
919
|
|
|
‡a
treatinghelicobacterpyloriinfectioninthefaceofgrowingantibioticresistance
‡A
Treating Helicobacter pylori infection in the face of growing antibiotic resistance
‡9
1
|
919
|
|
|
‡a
triplepylorusordoubleantroduodenalfistula
‡A
[Triple pylorus or double antroduodenal fistula]
‡9
1
|
919
|
|
|
‡a
tuberculosis1moreconsiderationinthedifferentialdiagnosisofapancreaticmass
‡A
Tuberculosis, one more consideration in the differential diagnosis of a pancreatic mass
‡9
1
|
919
|
|
|
‡a
ulcerativecolitisandautoimmunehemolyticanemia
‡A
[Ulcerative colitis and autoimmune hemolytic anemia]
‡9
1
|
919
|
|
|
‡a
usingtheinternettoevaluatetheopinionofpatientswithinflammatoryboweldiseasewithregardtotheavailableinformation
‡A
Using the internet to evaluate the opinion of patients with inflammatory bowel disease with regard to the available information.
‡9
1
|
919
|
|
|
‡a
villousatrophypersistenceinceliacdiseasedespitefollowingaglutenfreedietmustbeclarified
‡A
Villous atrophy persistence in celiac disease despite following a gluten-free diet must be clarified
‡9
1
|
919
|
|
|
‡a
visceralleishmaniasisdiagnosedbyduodenalbiopsy
‡A
[Visceral leishmaniasis diagnosed by duodenal biopsy]
‡9
1
|
919
|
|
|
‡a
doubtsandsimilaritiesbetweencrohnsdiseaseandhenochschonleinpurpura
‡A
Doubts and similarities between Crohn's disease and Henoch-Schönlein purpura
‡9
1
|
919
|
|
|
‡a
diagnosticproblemsinadultceliacdisease
‡A
[Diagnostic problems in adult celiac disease]
‡9
1
|
919
|
|
|
‡a
detectionofspecificigaantibodiesagainstanoveldeamidated8mergliadinpeptideinbloodplasmasamplesfromceliacpatients
‡A
Detection of specific IgA antibodies against a novel deamidated 8-Mer gliadin peptide in blood plasma samples from celiac patients
‡9
1
|
919
|
|
|
‡a
currentconceptsonmicroscopiccolitisevidencebasedstatementsandrecommendationsofthespanishmicroscopiccolitisgroup
‡A
Current concepts on microscopic colitis: evidence-based statements and recommendations of the Spanish Microscopic Colitis Group.
‡9
1
|
919
|
|
|
‡a
crohnsdiseasediagnosisduringadalimumabtreatment
‡A
Crohn's disease diagnosis during adalimumab treatment.
‡9
1
|
919
|
|
|
‡a
corrigendumfecalglutenpeptidesreveallimitationsofserologicaltestsandfoodquestionnairesformonitoringglutenfreedietinceliacdiseasepatients
‡A
Corrigendum: Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.
‡9
1
|
919
|
|
|
‡a
colonicpolypsdysplasiapredictivefactors
‡A
[Colonic polyps: dysplasia predictive factors]
‡9
1
|
919
|
|
|
‡a
collagenouscolitisrequirementforhighdosebudesonideasmaintenancetreatment
‡A
Collagenous colitis: Requirement for high-dose budesonide as maintenance treatment.
‡9
1
|
919
|
|
|
‡a
clinicalstatusqualityoflifeandworkproductivityincrohnsdiseasepatientsafter1yearoftreatmentwithadalimumab
‡A
Clinical status, quality of life, and work productivity in Crohn's disease patients after one year of treatment with adalimumab.
‡9
1
|
919
|
|
|
‡a
clinicalcharacteristicsassociatedmalignanciesandmanagementofprimarysclerosingcholangitisininflammatoryboweldiseasepatientsamulticentreretrospectivecohortstudy
‡A
Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study
‡9
1
|
919
|
|
|
‡a
chemokine100100motifreceptor2mediatesdendriticcellrecruitmenttothehumancolonbutisnotresponsiblefordifferencesobservedindendriticcellsubsetsphenotypeandfunctionbetweentheproximalanddistalcolon
‡A
Chemokine (C-C Motif) Receptor 2 Mediates Dendritic Cell Recruitment to the Human Colon but Is Not Responsible for Differences Observed in Dendritic Cell Subsets, Phenotype, and Function Between the Proximal and Distal Colon
‡9
1
|
919
|
|
|
‡a
changesinironmetabolisminchronichepatitis100
‡A
[Changes in iron metabolism in chronic hepatitis C]
‡9
1
|
919
|
|
|
‡a
catscratchesophagus
‡A
Cat scratch esophagus
‡9
1
|
919
|
|
|
‡a
autoimmunepancreatitisresponsetocorticoidstest
‡A
[Autoimmune pancreatitis: response to corticoids test]
‡9
1
|
919
|
|
|
‡a
atmosphericpressuredoesnotinfluenceacutediverticulardisease
‡A
Atmospheric pressure does not influence acute diverticular disease
‡9
1
|
919
|
|
|
‡a
ascorbatedependentdecreaseofthemucosalimmuneinflammatoryresponsetogliadinincoeliacdiseasepatients
‡A
Ascorbate-dependent decrease of the mucosal immune inflammatory response to gliadin in coeliac disease patients.
‡9
1
|
919
|
|
|
‡a
areworriesandconcernsinformationsideeffects
‡A
Are Worries and Concerns Information Side Effects?
‡9
1
|
919
|
|
|
‡a
approachtothepathogenesisandtreatmentofnonalcoholicsteatohepatitis
‡A
Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis
‡9
1
|
919
|
|
|
‡a
antralvascularectasiaetiopathogenicclinicalandtherapeuticaspects
‡A
[Antral vascular ectasia: etiopathogenic, clinical, and therapeutic aspects]
‡9
1
|
919
|
|
|
‡a
anothermultiplegastricanisakiasiscase
‡A
Another multiple gastric anisakiasis case
‡9
1
|
919
|
|
|
‡a
annularpancreasapotentiallyoverlookedcongenitalpancreaticanomaly
‡A
[Annular pancreas: a potentially overlooked congenital pancreatic anomaly]
‡9
1
|
919
|
|
|
‡a
unexpectedfindingofcatscratchcoloninascreeningcolonoscopy
‡A
An unexpected finding of cat scratch colon in a screening colonoscopy
‡9
1
|
919
|
|
|
‡a
amebiasisandintestinalinflammatorydisease
‡A
[Amebiasis and intestinal inflammatory disease]
‡9
1
|
919
|
|
|
‡a
alteredhumangutdendriticcellpropertiesinulcerativecolitisarereversedbylactobacillusplantarumextracellularencryptedpeptidestp
‡A
Altered human gut dendritic cell properties in ulcerative colitis are reversed by Lactobacillus plantarum extracellular encrypted peptide STp.
‡9
1
|
919
|
|
|
‡a
adalimumaborinfliximabforthepreventionofearlypostoperativerecurrenceofcrohndiseaseresultsfromtheeneidaregistry
‡A
Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry
‡9
1
|
919
|
|
|
‡a
acuteesophagealnecrosisresolvedin72hours
‡A
Acute esophageal necrosis resolved in 72 hours.
‡9
1
|
919
|
|
|
‡a
accuracyofureabreathtestperformedimmediatelyafteremergencyendoscopyinpepticulcerbleeding
‡A
Accuracy of Urea Breath Test Performed Immediately After Emergency Endoscopy in Peptic Ulcer Bleeding
‡9
1
|
919
|
|
|
‡a
abdominalmassmultiplelymphadenopathiesandpolyposis
‡A
Abdominal mass, multiple lymphadenopathies, and polyposis
‡9
1
|
946
|
|
|
‡a
b
‡9
1
|
996
|
|
|
‡2
ISNI|0000000139600415
|
996
|
|
|
‡2
LC|no2005026470
|
996
|
|
|
‡2
DNB|114507734X
|
996
|
|
|
‡2
ISNI|0000000021846444
|
996
|
|
|
‡2
BNC|981058521051306706
|
996
|
|
|
‡2
SUDOC|178768014
|
996
|
|
|
‡2
DNB|1056385707
|
996
|
|
|
‡2
PTBNP|1771617
|
996
|
|
|
‡2
DNB|1305606434
|
996
|
|
|
‡2
LC|no2006024640
|
996
|
|
|
‡2
SUDOC|241094852
|
996
|
|
|
‡2
ISNI|0000000048419565
|
996
|
|
|
‡2
NII|DA08945637
|
996
|
|
|
‡2
BNE|XX1018468
|
996
|
|
|
‡2
LC|no 97045830
|
996
|
|
|
‡2
DNB|1057173274
|
996
|
|
|
‡2
ISNI|0000000080160696
|
996
|
|
|
‡2
LC|n 92112892
|
996
|
|
|
‡2
RERO|A012099633
|
996
|
|
|
‡2
ISNI|0000000386856071
|
996
|
|
|
‡2
PTBNP|163017
|
996
|
|
|
‡2
RERO|A028350588
|
996
|
|
|
‡2
BNE|XX5474813
|
996
|
|
|
‡2
ISNI|0000000045624467
|
996
|
|
|
‡2
BNC|981060980793406706
|
996
|
|
|
‡2
NTA|142301302
|
996
|
|
|
‡2
LC|n 2010015273
|
996
|
|
|
‡2
PLWABN|9811788760805606
|
996
|
|
|
‡2
BNF|12413608
|
996
|
|
|
‡2
NTA|072296917
|
996
|
|
|
‡2
J9U|987007448923905171
|
996
|
|
|
‡2
DNB|1056225696
|
996
|
|
|
‡2
BIBSYS|10028012
|
996
|
|
|
‡2
BNCHL|10000000000000000204012
|
996
|
|
|
‡2
PLWABN|9810571355305606
|
996
|
|
|
‡2
BNE|XX1149363
|
996
|
|
|
‡2
PLWABN|9812399816705606
|
996
|
|
|
‡2
LC|n 84114075
|
996
|
|
|
‡2
ISNI|0000000023142854
|
996
|
|
|
‡2
BNF|12129542
|
996
|
|
|
‡2
DNB|1056649771
|
996
|
|
|
‡2
CAOONL|ncf10725572
|
996
|
|
|
‡2
LC|no2019188229
|
996
|
|
|
‡2
BNE|XX1699775
|
996
|
|
|
‡2
LC|no2016169308
|
996
|
|
|
‡2
RERO|A017693982
|
996
|
|
|
‡2
DNB|1056270403
|
996
|
|
|
‡2
ISNI|0000000497844356
|
996
|
|
|
‡2
SUDOC|135346711
|
996
|
|
|
‡2
PTBNP|986672
|
996
|
|
|
‡2
BNCHL|10000000000000000135624
|
996
|
|
|
‡2
ISNI|0000000042723400
|
996
|
|
|
‡2
ISNI|0000000021565175
|
996
|
|
|
‡2
NII|DA15573714
|
996
|
|
|
‡2
RERO|A013302955
|
996
|
|
|
‡2
LC|no2009133173
|
996
|
|
|
‡2
LC|n 00098658
|
996
|
|
|
‡2
BNE|XX1365579
|
996
|
|
|
‡2
SUDOC|030811007
|
996
|
|
|
‡2
ISNI|0000000059873376
|
996
|
|
|
‡2
ISNI|000000003499119X
|
996
|
|
|
‡2
BNCHL|10000000000000000168865
|
996
|
|
|
‡2
SUDOC|172176522
|
996
|
|
|
‡2
ISNI|0000000076888502
|
996
|
|
|
‡2
ISNI|0000000033830503
|
996
|
|
|
‡2
LC|no2003109886
|
996
|
|
|
‡2
DNB|1056496630
|
996
|
|
|
‡2
SUDOC|05577637X
|
996
|
|
|
‡2
BNE|XX1232231
|
996
|
|
|
‡2
CAOONL|ncf11318326
|
996
|
|
|
‡2
BNE|XX1050920
|
996
|
|
|
‡2
RERO|A025316810
|
996
|
|
|
‡2
LC|nr 99022690
|
996
|
|
|
‡2
J9U|987007420312205171
|
996
|
|
|
‡2
CAOONL|ncf12029143
|
996
|
|
|
‡2
SUDOC|150347405
|
996
|
|
|
‡2
ISNI|000000008126848X
|
996
|
|
|
‡2
ISNI|0000000029248780
|
996
|
|
|
‡2
BNCHL|10000000000000000127026
|
996
|
|
|
‡2
BNF|17704292
|
996
|
|
|
‡2
NUKAT|n 2021141457
|
996
|
|
|
‡2
NTA|131291416
|
996
|
|
|
‡2
DNB|1216526745
|
996
|
|
|
‡2
BNE|XX6134235
|
996
|
|
|
‡2
LC|no2008184849
|
996
|
|
|
‡2
SUDOC|130061972
|
996
|
|
|
‡2
LC|n 98031003
|
996
|
|
|
‡2
NII|DA14779077
|
996
|
|
|
‡2
BNCHL|10000000000000000852294
|
996
|
|
|
‡2
LC|no2013051083
|
996
|
|
|
‡2
BIBSYS|98055433
|
996
|
|
|
‡2
ISNI|0000000054738570
|
996
|
|
|
‡2
BIBSYS|90667717
|
996
|
|
|
‡2
BNC|981058514509906706
|
996
|
|
|
‡2
BNE|XX923636
|
996
|
|
|
‡2
DNB|1189183013
|
996
|
|
|
‡2
LC|n 2024183614
|
996
|
|
|
‡2
LC|no2023000587
|
996
|
|
|
‡2
LC|n 81115142
|
996
|
|
|
‡2
NUKAT|n 2011104705
|
996
|
|
|
‡2
SUDOC|075243474
|
996
|
|
|
‡2
LC|n 2011077526
|
996
|
|
|
‡2
BNE|XX876200
|
996
|
|
|
‡2
BAV|495_133974
|
996
|
|
|
‡2
BNCHL|10000000000000000083070
|
996
|
|
|
‡2
RERO|A026009037
|
996
|
|
|
‡2
DNB|13899613X
|
996
|
|
|
‡2
DNB|1057042412
|
996
|
|
|
‡2
BNF|12215115
|
996
|
|
|
‡2
LC|no2004115498
|
996
|
|
|
‡2
DNB|111520534X
|
996
|
|
|
‡2
LC|no2018055706
|
996
|
|
|
‡2
SUDOC|167255355
|
996
|
|
|
‡2
LC|nr 98033670
|
996
|
|
|
‡2
ISNI|0000000047060108
|
996
|
|
|
‡2
DNB|131567291X
|
996
|
|
|
‡2
SUDOC|134486684
|
996
|
|
|
‡2
DNB|1056193034
|
996
|
|
|
‡2
DNB|1222683377
|
996
|
|
|
‡2
LC|no 95045197
|
996
|
|
|
‡2
BNF|17012534
|
996
|
|
|
‡2
CAOONL|ncf10693371
|
996
|
|
|
‡2
ISNI|0000000067858432
|
996
|
|
|
‡2
PLWABN|9812829927305606
|
996
|
|
|
‡2
DNB|1157210597
|
996
|
|
|
‡2
LC|nr 94024631
|
996
|
|
|
‡2
LC|no2017136996
|
996
|
|
|
‡2
LC|no2019044269
|
996
|
|
|
‡2
LC|no2002071074
|
996
|
|
|
‡2
ISNI|000000004892289X
|
996
|
|
|
‡2
BNE|XX1133836
|
996
|
|
|
‡2
BNC|981058517501406706
|
996
|
|
|
‡2
LC|n 2013025385
|
996
|
|
|
‡2
SUDOC|236847473
|
996
|
|
|
‡2
LC|no2009005020
|
996
|
|
|
‡2
BNCHL|10000000000000000042974
|
996
|
|
|
‡2
SUDOC|18866579X
|
996
|
|
|
‡2
LC|n 97078063
|
996
|
|
|
‡2
LC|n 80006513
|
996
|
|
|
‡2
ISNI|0000000498698805
|
996
|
|
|
‡2
LC|no2009134617
|
996
|
|
|
‡2
LC|ns2013002749
|
996
|
|
|
‡2
DNB|133220001
|
996
|
|
|
‡2
ISNI|0000000081883220
|
996
|
|
|
‡2
SUDOC|253497043
|
996
|
|
|
‡2
LC|no2014021092
|
996
|
|
|
‡2
BNE|XX879919
|
996
|
|
|
‡2
DNB|1333564422
|
996
|
|
|
‡2
SELIBR|317414
|
996
|
|
|
‡2
NTA|264788753
|
996
|
|
|
‡2
J9U|987007383998905171
|
996
|
|
|
‡2
LC|n 81050602
|
996
|
|
|
‡2
PTBNP|1803777
|
996
|
|
|
‡2
LC|no2003122450
|
996
|
|
|
‡2
DNB|1057229555
|
996
|
|
|
‡2
DNB|129563757
|
996
|
|
|
‡2
LC|n 2004099466
|
996
|
|
|
‡2
SUDOC|140230025
|
996
|
|
|
‡2
DNB|140752226
|
996
|
|
|
‡2
LC|n 2019034159
|
996
|
|
|
‡2
LC|no2022080642
|
996
|
|
|
‡2
LC|ns2018000357
|
996
|
|
|
‡2
PTBNP|1807705
|
996
|
|
|
‡2
BNF|14577722
|
996
|
|
|
‡2
J9U|987007432844405171
|
996
|
|
|
‡2
BNC|981059289071206706
|
996
|
|
|
‡2
NTA|419274839
|
996
|
|
|
‡2
DNB|1056292555
|
996
|
|
|
‡2
BNE|XX1269475
|
996
|
|
|
‡2
DNB|1056258497
|
996
|
|
|
‡2
LC|n 2017017952
|
996
|
|
|
‡2
LC|no2006048920
|
996
|
|
|
‡2
ISNI|0000000049524420
|
996
|
|
|
‡2
LC|nr 96025184
|
996
|
|
|
‡2
BNCHL|10000000000000000171817
|
996
|
|
|
‡2
LC|n 90715543
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|